Covid-19 Pandemic Response

At Medmarc, the health and well being of our community is a top priority locally and abroad. We will continue to refer to the Centers for Disease Control and Prevention, the World Health Organization, and other public health agencies to determine the safest course of action for everyone. We also understand your business is relying on us to provide you with the protection and service you need for the coverage you have with us.

Medmarc has supported the life sciences industry for over 40 years and we will continue to do so. We are proud of our current insureds who are working so hard to combat this virus and keep us all safe, and we are ready to do our part to support their efforts as best we can.

We have developed this page to be a resource guide for our insureds and brokers and will continue to add as we navigate this very fluid situation.

PREMIUM PAYMENTS

Medmarc recognizes the potential for financial hardship to your business during this crisis. We will work with you and your broker to make reasonable accommodations to assist you should you need additional time to make premium payments. We will remain in compliance with the Departments of Insurance (DOI) for individual states which have guidance regarding grace periods. For a current list of relevant bulletins, please visit the National Association of Insurance Commissioners' Corona Virus Resource Center.

If you have any questions regarding premium payments or your account status, please let us know by contacting your broker or Medmarc directly. Visit Contact Us for a Medmarc representative in your state.

PENDING CLAIMS

Medmarc currently does not anticipate any interruption to our services. Every claims representative has the ability to work remotely with full computer, phone, and support services. Regular mail processing will continue. You will be able to contact us through all means with the exception of in person meetings, and we will stay in contact with you. We have made preparations for staff to be fully functional during this timeframe.

If you have any questions about a pending claim, please call your claims representative assigned to you previously. Your claims representative is able to assist you with many questions you may have related to the status of your file, including whether your scheduled deposition, hearing, or trial may be postponed.

If you need to submit a claim, you can do so on our Report a Claim page.

 

COVID-19 Resources

Previously Recorded on May 27, 2020

The following topics will be covered in this webinar:

  • Outlining potential product liability risk involving COVID (defect claims involving marketing/advertising, warranties, and warnings)
  • Tips on how to mitigate the risks of potential product liability claims involving COVID and how to defend them.
  • Discussion regarding updates on PREP Act immunity and warranty disclaimers. 
  • Avoiding price gouging liability

View On-Demand Now

Paycheck Protection Program


An SBA loan that helps businesses keep their workforce employed during the Coronavirus (COVID-19) crisis. Go direct to SBA.gov for up to date information. More...

The FDA is scrambling to meet the demands imposed by the COVID-19 outbreak, including a series of guidances dealing with a variety of issues. However, the predicament has also prompted two pieces of legislation, one an economic stimulus package and the other a bill that would tie the FDA’s hands where regulation of lab-developed tests is concerned.  MORE...

Previously Recorded on March 31, 2020

View On Demand Now

Device manufacturers (as well as drug manufacturers, distributors, and health care providers) are struggling to answer many questions regarding their potential products liability in responding to the COVID-19 pandemic. Fortunately, as discussed below, the PREP Act and the recent declaration by the Secretary for the Department of Health and Human Services provides significant immunity from COVID-19 lawsuits.  MORE...

Previously recorded April 2, 2020
View On-demand Now...

With the Coronavirus (COVID-19) pandemic, medical device companies are facing disruptions to their supply chains, vendors who simply stop providing services, and a denuded work force.  Who is responsible when the supply chain fails due to a pandemic?  What should a company do when its vendors stop all work because their employees must stay home?  And what can a company do when it can’t meet its supply obligations due to its own employees in quarantine? MORE...

FDA is working with U.S. Government partners, including CDC, and international partners to address the coronavirus disease 2019 (COVID-19) outbreak.

Stay up-to-date on the latest COVID-19 information from the FDA

March 2020

The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from threats including emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support continuity and response efforts to this pandemic.

Download the Final Guidance Document

The Advanced Medical Technology Association (AdvaMed), is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.

As they continue to assess and respond to a crisis that continues to evolve, AdvaMed’s objective is to pool and disseminate industry knowledge, and share developments among our membership.

They have created a COVID-19 Outbreak page dedicated to the industry:

AdvaMed COVID-19 Outbreak Page

Request More Information

Optional

Select a subject
Please verify and then select Send